Conference Coverage

Osteoprotegerin ups risk of vascular events in type 1 diabetes

Publish date: July 22, 2013

 

AT THE ANNUAL ADA SCIENTIFIC SESSIONS

pwendling@frontlinemedcom.com

Pages

Recommended Reading

A third of CHD patients may undergo unnecessary lipid testing
MDedge Family Medicine
Empagliflozin improves cardiovascular risk factors in T2DM
MDedge Family Medicine
Twice daily regimen eases aspirin resistance in diabetes
MDedge Family Medicine
Orbital atherectomy shown safe, effective in coronaries
MDedge Family Medicine
FDA warns about serious GI symptoms with olmesartan
MDedge Family Medicine
Low vitamin D effects on CHD risk vary by race
MDedge Family Medicine
Tight inflammation control could reduce CV risk in men with gout
MDedge Family Medicine
Roche halts studies of experimental type 2 diabetes drug
MDedge Family Medicine
Excessive visceral fat linked to increased risk of CVD, cancer
MDedge Family Medicine
Longer duration of obesity linked to coronary calcification
MDedge Family Medicine